ESSA Pharma Inc.
(Redirecționat de la Actiuni ESSA Pharma Inc.)
Pagina dedicata companiei ESSA Pharma Inc. listata cu simbolul CA.EPI
Descriere companie[edit | ]
ESSA Pharma Inc. (www.essapharma.com) is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.
Grafic actiuni companie[edit | ]